The authors of “Overdiagnosis of Adult ADHD Is Exacerbating the Stimulant Shortage” reply to a letter to the editor. We welcome the input and opportunity for discussion. There is much on which we can ...

SAN FRANCISCO — After more than a decade of development and more than 2 years of frequently searing controversy, the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) ...

Despite oft-heard complaints, the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) continues to be the primary diagnostic manual used by mental health professionals. However, in the last ...

NEW ORLEANS -- At the American Psychiatric Association (APA) annual meeting, MedPage Today sat down with Paul Appelbaum, MD, chair of the Diagnostic and Statistical Manual of Mental Disorders (DSM) ...

The American Psychiatric Association just reported a surprisingly large yearly deficit of $350,000. This was caused by reduced publishing profits, poor attendance at its annual meeting, rapidly ...

Please provide your email address to receive an email when new articles are posted on . Significant differences between the two instruments include the PTSD Checklist for DSM-5 (PCL-5) having three ...

Each month, Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. The fifth edition of the ...

Mental health professionals use the DSM to standardize the diagnosis and treatment processes for mental health conditions, including types of depression. The Diagnostic and Statistical Manual of ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I am continuing my ongoing series about the ...

Arthur Caplan is the director of the division of medical ethics at the NYU Grossman School of Medicine. The newly revised Diagnostic and Statistical Manual of the American Psychiatric Association—DSM ...

This letter refutes the “overdiagnosis” narrative, blaming the stimulant shortage on DEA regulatory failures, clinical constraints, and recognition of historical underdiagnosis. By concluding that ...